N
New Jersey Hematology Oncology Associates | Brick Office
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ruxolitinib
Parsaclisib
Azacitidine
Atezolizumab
Trastuzumab
Ibrutinib
Inavolisib
nivolumab
Alectinib
Decitabine
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 18 total trials
The primary objectives of this study are to assess: (1) whether the combination of BP1001 plus venetoclax plus decitabine provides greater efficacy (...
Enrolling
Acute Myeloid Leukemia (AML)
Drug: BP1001 plus decitabine
Drug: BP1001 in combination with Ventoclax plus decitabine
Trial sponsors
B
H
H
O
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems